R. Jeremy Nichols, PhD, is a senior research scientist in the Stanford School of Medicine department of pathology. He obtained a BS degree with honors from Austin Peay State University and a PhD from the Medical College of Wisconsin, where he worked in the laboratory of Dr. Paula Traktman. As a postdoctoral fellow with Professor Dario Alessi at the Medical Research Council Protein Phosphorylation Unit in Dundee, Scotland, Dr. Nichols pursued his interest in cellular signaling studying the role of LRRK2 in cells and the genetic causes of Parkinson's disease (PD). Dr. Nichols was Director of Signal Transduction and LRRK2 Biology at the Parkinson’s Institute and Clinical Center in Sunnyvale, CA. His laboratory moved to the Stanford University department of pathology in 2018. Dr. Nichols’ research focuses on studying the biochemical reactions and molecules linked to the proteins implicated in PD.
Associated Grants
-
Exploring the Use of Molecules that Stabilize the Interaction between LRRK2 Kinase and the 14-3-3 Adapter Protein as a Neuroprotective Therapy for Parkinson’s Disease
2023
-
Assessment of LRRK2 Activity and Neurodegeneration Markers in Postmortem Brain Samples of Idiopathic and LRRK2-associated Parkinson’s Disease
2021
-
LRRK2 Inhibitors for the Treatment of Gastrointestinal Symptoms of Parkinson’s Disease
2018
-